Sign in
APLMW Stock Price, Chart, Stats & News
Apollomics, Inc.
Save
Apollomics, Inc. (APLMW) does not currently pay a dividend.
169.97M
Market cap
–
Current P/E
–
Forward P/E
APLMW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -22.66% |
Operating margin | -395.86% |
Pretax margin | -446.29% |
Net margin | -450.04% |
Effective tax rate | -0.84% |
ROA | -280.49% |
ROE | -13385.41% |
D/E | -0.17x |
Interest coverage ratio | -783.80x |
APLMW valuation
P/E | – |
P/S | 2.75x |
P/B | -4.33x |
P/CF | -1.49x |
P/FCF | -1.49x |
P/OCF | -1.49x |
PEG | -0.01x |
EV multiple | -0.72x |
About
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements.
Similar securities
Based on sector and market capitalization
Report issue